Vol VII, Issue 1 Date of Publication: January 10, 2022
DOI: https://doi.org/10.20529/IJME.2021.049

, PDF Downloads:

Drug testing: Who pays? Who benefits?

Nancy Olivieri
The public is not under any illusion about the crimes and misdemeanours of the pharmaceutical industry. As of 2019, in the US, the industry (“Pharma”) was considered more negatively than oil and banking – and the US government (1). Yes, until recently, at least in the US - Donald Trump enjoyed a better public rating than Big Pharma.

Copyright and license
©Indian Journal of Medical Ethics 2021: Open Access and Distributed under the Creative Commons license ( CC BY-NC-ND 4.0),
which permits only non-commercial and non-modified sharing in any medium, provided the original author(s) and source are credited.

Full Text


Leave a Reply

Your email address will not be published. Required fields are marked *
Please restrict your comment preferably to 800 words
Comments are moderated. Approval can take up to 48 hours.

Help IJME keep its content free. You can support us from as little as Rs. 500 Make a Donation